APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Epidemic Diarrhea Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Swine Epidemic Diarrhea Vaccines Market Analysis and Forecast 2026-2032

2 January 2026195 pages

Choose your research edition.

Industry ResearchSwine Epidemic Diarrhea Vaccines Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Epidemic Diarrhea Vaccines Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Swine Epidemic Diarrhea Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Epidemic Diarrhea Vaccines Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Epidemic Diarrhea Vaccines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Swine Epidemic Diarrhea Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Swine Epidemic Diarrhea Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Swine Epidemic Diarrhea Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Swine Epidemic Diarrhea Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Swine Epidemic Diarrhea Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Swine Epidemic Diarrhea Vaccines include CAVAC, Qilu Animal Health, Zoetis, Nisseiken, Komipharm, Harrisvaccines, Inc. and Green Cross Veterinary Products, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Swine Epidemic Diarrhea Vaccines, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Swine Epidemic Diarrhea Vaccines, also provides the revenue of main regions and countries. Of the upcoming market potential for Swine Epidemic Diarrhea Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Swine Epidemic Diarrhea Vaccines revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Swine Epidemic Diarrhea Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Swine Epidemic Diarrhea Vaccines revenue, projected growth trends, production technology, application and end-user industry.

Swine Epidemic Diarrhea Vaccines Segment by Company

CAVAC

Qilu Animal Health

Zoetis

Nisseiken

Komipharm

Harrisvaccines, Inc.

Green Cross Veterinary Products

Swine Epidemic Diarrhea Vaccines Segment by Type

Live Vaccines

Killed Vaccines

Swine Epidemic Diarrhea Vaccines Segment by Application

Piglets

Adults Pigs

Swine Epidemic Diarrhea Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Epidemic Diarrhea Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Epidemic Diarrhea Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Epidemic Diarrhea Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Swine Epidemic Diarrhea Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Swine Epidemic Diarrhea Vaccines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Epidemic Diarrhea Vaccines revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Live Vaccines Major Player Table 3. Killed Vaccines Major Player Table 4. Global Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Piglets Major Player Table 6. Adults Pigs Major Player Table 7. Swine Epidemic Diarrhea Vaccines Industry Trends Table 8. Swine Epidemic Diarrhea Vaccines Industry Drivers Table 9. Swine Epidemic Diarrhea Vaccines Industry Opportunities and Challenges Table 10. Swine Epidemic Diarrhea Vaccines Industry Restraints Table 11. Global Swine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Swine Epidemic Diarrhea Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Swine Epidemic Diarrhea Vaccines Market Share by Region (2021-2026) Table 14. Global Swine Epidemic Diarrhea Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Swine Epidemic Diarrhea Vaccines Market Share by Region (2027-2032) Table 16. Global Swine Epidemic Diarrhea Vaccines Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Players (2021-2026) Table 18. Global Swine Epidemic Diarrhea Vaccines Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Swine Epidemic Diarrhea Vaccines Key Players Headquarters & Area Served Table 20. Global Swine Epidemic Diarrhea Vaccines Players, Product Type & Application Table 21. Global Swine Epidemic Diarrhea Vaccines Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Swine Epidemic Diarrhea Vaccines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Swine Epidemic Diarrhea Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Swine Epidemic Diarrhea Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Type (2021-2026) Table 28. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Type (2027-2032) Table 29. Global Swine Epidemic Diarrhea Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Swine Epidemic Diarrhea Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2021-2026) Table 33. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2027-2032) Table 34. CAVAC Company Information Table 35. CAVAC Business Overview Table 36. CAVAC Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. CAVAC Swine Epidemic Diarrhea Vaccines Product Portfolio Table 38. CAVAC Recent Development Table 39. Qilu Animal Health Company Information Table 40. Qilu Animal Health Business Overview Table 41. Qilu Animal Health Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Qilu Animal Health Swine Epidemic Diarrhea Vaccines Product Portfolio Table 43. Qilu Animal Health Recent Development Table 44. Zoetis Company Information Table 45. Zoetis Business Overview Table 46. Zoetis Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Zoetis Swine Epidemic Diarrhea Vaccines Product Portfolio Table 48. Zoetis Recent Development Table 49. Nisseiken Company Information Table 50. Nisseiken Business Overview Table 51. Nisseiken Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Nisseiken Swine Epidemic Diarrhea Vaccines Product Portfolio Table 53. Nisseiken Recent Development Table 54. Komipharm Company Information Table 55. Komipharm Business Overview Table 56. Komipharm Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Komipharm Swine Epidemic Diarrhea Vaccines Product Portfolio Table 58. Komipharm Recent Development Table 59. Harrisvaccines, Inc. Company Information Table 60. Harrisvaccines, Inc. Business Overview Table 61. Harrisvaccines, Inc. Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Harrisvaccines, Inc. Swine Epidemic Diarrhea Vaccines Product Portfolio Table 63. Harrisvaccines, Inc. Recent Development Table 64. Green Cross Veterinary Products Company Information Table 65. Green Cross Veterinary Products Business Overview Table 66. Green Cross Veterinary Products Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Green Cross Veterinary Products Swine Epidemic Diarrhea Vaccines Product Portfolio Table 68. Green Cross Veterinary Products Recent Development Table 69. North America Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 70. North America Swine Epidemic Diarrhea Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 71. North America Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 72. North America Swine Epidemic Diarrhea Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 73. North America Swine Epidemic Diarrhea Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Swine Epidemic Diarrhea Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 75. North America Swine Epidemic Diarrhea Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 76. Europe Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 77. Europe Swine Epidemic Diarrhea Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 78. Europe Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 79. Europe Swine Epidemic Diarrhea Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 80. Europe Swine Epidemic Diarrhea Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. Europe Swine Epidemic Diarrhea Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 82. Europe Swine Epidemic Diarrhea Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 83. China Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 84. China Swine Epidemic Diarrhea Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 85. China Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 86. China Swine Epidemic Diarrhea Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 87. Asia Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 88. Asia Swine Epidemic Diarrhea Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 89. Asia Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 90. Asia Swine Epidemic Diarrhea Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 91. Asia Swine Epidemic Diarrhea Vaccines Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Asia Swine Epidemic Diarrhea Vaccines Revenue by Region (US$ Million) & (2021-2026) Table 93. Asia Swine Epidemic Diarrhea Vaccines Revenue by Region (US$ Million) & (2027-2032) Table 94. SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 95. SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 96. SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 97. SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 98. SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 100. SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Swine Epidemic Diarrhea Vaccines Image Figure 2. Global Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Epidemic Diarrhea Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Live Vaccines Image Figure 5. Killed Vaccines Image Figure 6. Global Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Swine Epidemic Diarrhea Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Piglets Image Figure 9. Adults Pigs Image Figure 10. Global Swine Epidemic Diarrhea Vaccines Market Size (US$ Million) & (2021-2032) Figure 11. Global Swine Epidemic Diarrhea Vaccines Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Swine Epidemic Diarrhea Vaccines Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Swine Epidemic Diarrhea Vaccines Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Swine Epidemic Diarrhea Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Type (2021-2032) Figure 18. Global Swine Epidemic Diarrhea Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2021-2032) Figure 21. North America Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Swine Epidemic Diarrhea Vaccines Revenue Share by Type (2021-2032) Figure 23. North America Swine Epidemic Diarrhea Vaccines Revenue Share by Application (2021-2032) Figure 24. North America Swine Epidemic Diarrhea Vaccines Revenue Share by Country (2021-2032) Figure 25. United States Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Swine Epidemic Diarrhea Vaccines Revenue Share by Type (2021-2032) Figure 30. Europe Swine Epidemic Diarrhea Vaccines Revenue Share by Application (2021-2032) Figure 31. Europe Swine Epidemic Diarrhea Vaccines Revenue Share by Country (2021-2032) Figure 32. Germany Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Swine Epidemic Diarrhea Vaccines Revenue Share by Type (2021-2032) Figure 42. China Swine Epidemic Diarrhea Vaccines Revenue Share by Application (2021-2032) Figure 43. Asia Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Swine Epidemic Diarrhea Vaccines Revenue Share by Type (2021-2032) Figure 45. Asia Swine Epidemic Diarrhea Vaccines Revenue Share by Application (2021-2032) Figure 46. Asia Swine Epidemic Diarrhea Vaccines Revenue Share by Region (2021-2032) Figure 47. Japan Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Swine Epidemic Diarrhea Vaccines Revenue Share by Type (2021-2032) Figure 55. SAMEA Swine Epidemic Diarrhea Vaccines Revenue Share by Application (2021-2032) Figure 56. SAMEA Swine Epidemic Diarrhea Vaccines Revenue Share by Country (2021-2032) Figure 57. Brazil Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Swine Epidemic Diarrhea Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Piglets
  • Adults Pigs
Companies covered
  • CAVAC
  • Qilu Animal Health
  • Zoetis
  • Nisseiken
  • Komipharm
  • Harrisvaccines, Inc.
  • Green Cross Veterinary Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Swine Epidemic Diarrhea Vaccines Market by Type
  3. 1.2.1 Global Swine Epidemic Diarrhea Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Live Vaccines
  5. 1.2.3 Killed Vaccines
  6. 1.3 Swine Epidemic Diarrhea Vaccines Market by Application
  7. 1.3.1 Global Swine Epidemic Diarrhea Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Piglets
  9. 1.3.3 Adults Pigs
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Swine Epidemic Diarrhea Vaccines Market Dynamics
  1. 2.1 Swine Epidemic Diarrhea Vaccines Industry Trends
  2. 2.2 Swine Epidemic Diarrhea Vaccines Industry Drivers
  3. 2.3 Swine Epidemic Diarrhea Vaccines Industry Opportunities and Challenges
  4. 2.4 Swine Epidemic Diarrhea Vaccines Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Swine Epidemic Diarrhea Vaccines Market Perspective (2021-2032)
  2. 3.2 Global Swine Epidemic Diarrhea Vaccines Growth Trends by Region
  3. 3.2.1 Global Swine Epidemic Diarrhea Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Swine Epidemic Diarrhea Vaccines Market Size by Region (2021-2026)
  5. 3.2.3 Global Swine Epidemic Diarrhea Vaccines Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Swine Epidemic Diarrhea Vaccines Revenue by Players
  2. 4.1.1 Global Swine Epidemic Diarrhea Vaccines Revenue by Players (2021-2026)
  3. 4.1.2 Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Swine Epidemic Diarrhea Vaccines Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Swine Epidemic Diarrhea Vaccines Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Swine Epidemic Diarrhea Vaccines Key Players Headquarters & Area Served
  7. 4.4 Global Swine Epidemic Diarrhea Vaccines Players, Product Type & Application
  8. 4.5 Global Swine Epidemic Diarrhea Vaccines Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Swine Epidemic Diarrhea Vaccines Market CR5 and HHI
  11. 4.6.3 2025 Swine Epidemic Diarrhea Vaccines Tier 1, Tier 2, and Tier 3
5 Swine Epidemic Diarrhea Vaccines Market Size by Type
  1. 5.1 Global Swine Epidemic Diarrhea Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2032)
  3. 5.3 Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Type (2021-2032)
6 Swine Epidemic Diarrhea Vaccines Market Size by Application
  1. 6.1 Global Swine Epidemic Diarrhea Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2032)
  3. 6.3 Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 CAVAC
  2. 7.1.1 CAVAC Company Information
  3. 7.1.2 CAVAC Business Overview
  4. 7.1.3 CAVAC Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (2021-2026)
  5. 7.1.4 CAVAC Swine Epidemic Diarrhea Vaccines Product Portfolio
  6. 7.1.5 CAVAC Recent Developments
  7. 7.2 Qilu Animal Health
  8. 7.2.1 Qilu Animal Health Company Information
  9. 7.2.2 Qilu Animal Health Business Overview
  10. 7.2.3 Qilu Animal Health Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Qilu Animal Health Swine Epidemic Diarrhea Vaccines Product Portfolio
  12. 7.2.5 Qilu Animal Health Recent Developments
  13. 7.3 Zoetis
  14. 7.3.1 Zoetis Company Information
  15. 7.3.2 Zoetis Business Overview
  16. 7.3.3 Zoetis Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Zoetis Swine Epidemic Diarrhea Vaccines Product Portfolio
  18. 7.3.5 Zoetis Recent Developments
  19. 7.4 Nisseiken
  20. 7.4.1 Nisseiken Company Information
  21. 7.4.2 Nisseiken Business Overview
  22. 7.4.3 Nisseiken Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Nisseiken Swine Epidemic Diarrhea Vaccines Product Portfolio
  24. 7.4.5 Nisseiken Recent Developments
  25. 7.5 Komipharm
  26. 7.5.1 Komipharm Company Information
  27. 7.5.2 Komipharm Business Overview
  28. 7.5.3 Komipharm Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Komipharm Swine Epidemic Diarrhea Vaccines Product Portfolio
  30. 7.5.5 Komipharm Recent Developments
  31. 7.6 Harrisvaccines, Inc.
  32. 7.6.1 Harrisvaccines, Inc. Company Information
  33. 7.6.2 Harrisvaccines, Inc. Business Overview
  34. 7.6.3 Harrisvaccines, Inc. Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Harrisvaccines, Inc. Swine Epidemic Diarrhea Vaccines Product Portfolio
  36. 7.6.5 Harrisvaccines, Inc. Recent Developments
  37. 7.7 Green Cross Veterinary Products
  38. 7.7.1 Green Cross Veterinary Products Company Information
  39. 7.7.2 Green Cross Veterinary Products Business Overview
  40. 7.7.3 Green Cross Veterinary Products Swine Epidemic Diarrhea Vaccines Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Green Cross Veterinary Products Swine Epidemic Diarrhea Vaccines Product Portfolio
  42. 7.7.5 Green Cross Veterinary Products Recent Developments
8 North America
  1. 8.1 North America Swine Epidemic Diarrhea Vaccines Revenue (2021-2032)
  2. 8.2 North America Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2032)
  3. 8.2.1 North America Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2026)
  4. 8.2.2 North America Swine Epidemic Diarrhea Vaccines Revenue by Type (2027-2032)
  5. 8.3 North America Swine Epidemic Diarrhea Vaccines Revenue Share by Type (2021-2032)
  6. 8.4 North America Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2032)
  7. 8.4.1 North America Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2026)
  8. 8.4.2 North America Swine Epidemic Diarrhea Vaccines Revenue by Application (2027-2032)
  9. 8.5 North America Swine Epidemic Diarrhea Vaccines Revenue Share by Application (2021-2032)
  10. 8.6 North America Swine Epidemic Diarrhea Vaccines Revenue by Country
  11. 8.6.1 North America Swine Epidemic Diarrhea Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Swine Epidemic Diarrhea Vaccines Revenue by Country (2021-2026)
  13. 8.6.3 North America Swine Epidemic Diarrhea Vaccines Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Swine Epidemic Diarrhea Vaccines Revenue (2021-2032)
  2. 9.2 Europe Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2032)
  3. 9.2.1 Europe Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2026)
  4. 9.2.2 Europe Swine Epidemic Diarrhea Vaccines Revenue by Type (2027-2032)
  5. 9.3 Europe Swine Epidemic Diarrhea Vaccines Revenue Share by Type (2021-2032)
  6. 9.4 Europe Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2032)
  7. 9.4.1 Europe Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2026)
  8. 9.4.2 Europe Swine Epidemic Diarrhea Vaccines Revenue by Application (2027-2032)
  9. 9.5 Europe Swine Epidemic Diarrhea Vaccines Revenue Share by Application (2021-2032)
  10. 9.6 Europe Swine Epidemic Diarrhea Vaccines Revenue by Country
  11. 9.6.1 Europe Swine Epidemic Diarrhea Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Swine Epidemic Diarrhea Vaccines Revenue by Country (2021-2026)
  13. 9.6.3 Europe Swine Epidemic Diarrhea Vaccines Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Swine Epidemic Diarrhea Vaccines Revenue (2021-2032)
  2. 10.2 China Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2032)
  3. 10.2.1 China Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2026)
  4. 10.2.2 China Swine Epidemic Diarrhea Vaccines Revenue by Type (2027-2032)
  5. 10.3 China Swine Epidemic Diarrhea Vaccines Revenue Share by Type (2021-2032)
  6. 10.4 China Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2032)
  7. 10.4.1 China Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2026)
  8. 10.4.2 China Swine Epidemic Diarrhea Vaccines Revenue by Application (2027-2032)
  9. 10.5 China Swine Epidemic Diarrhea Vaccines Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Swine Epidemic Diarrhea Vaccines Revenue (2021-2032)
  2. 11.2 Asia Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2032)
  3. 11.2.1 Asia Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2026)
  4. 11.2.2 Asia Swine Epidemic Diarrhea Vaccines Revenue by Type (2027-2032)
  5. 11.3 Asia Swine Epidemic Diarrhea Vaccines Revenue Share by Type (2021-2032)
  6. 11.4 Asia Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2032)
  7. 11.4.1 Asia Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2026)
  8. 11.4.2 Asia Swine Epidemic Diarrhea Vaccines Revenue by Application (2027-2032)
  9. 11.5 Asia Swine Epidemic Diarrhea Vaccines Revenue Share by Application (2021-2032)
  10. 11.6 Asia Swine Epidemic Diarrhea Vaccines Revenue by Country
  11. 11.6.1 Asia Swine Epidemic Diarrhea Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Swine Epidemic Diarrhea Vaccines Revenue by Country (2021-2026)
  13. 11.6.3 Asia Swine Epidemic Diarrhea Vaccines Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Swine Epidemic Diarrhea Vaccines Revenue (2021-2032)
  2. 12.2 SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Type (2027-2032)
  5. 12.3 SAMEA Swine Epidemic Diarrhea Vaccines Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Application (2027-2032)
  9. 12.5 SAMEA Swine Epidemic Diarrhea Vaccines Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Country
  11. 12.6.1 SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Swine Epidemic Diarrhea Vaccines Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst